Literature DB >> 12650244

Epidemiology of bacterial diseases in Norwegian aquaculture--a description based on antibiotic prescription data for the ten-year period 1991 to 2000.

A Lillehaug1, B T Lunestad, K Grave.   

Abstract

In Norway, antibacterial drugs for use in farmed fishes have to be prescribed by a veterinarian. Moreover, a national surveillance programme requires that copies of all prescriptions be sent to the Directorate of Fisheries. The prescriptions give information regarding fish farm and locality, weight and species of fish to be medicated, diagnosis, type and amount of drug prescribed, and date. These prescription data for the 10 yr period 1991 to 2000 have been recorded and systematised. A total of 6322 prescriptions issued for 11 fish species were registered; Atlantic salmon represented 87% of the prescriptions, rainbow trout 4.5%, arctic char 0.3%, turbot 3.8%, halibut 2.1%, Atlantic cod 1.2%, and European eel 0.3%. European sea-bass, wolf-fish, coalfish and wrasse represented a total of 0.4% of the prescriptions. Furunculosis was the most frequently given diagnosis in Atlantic salmon, accounting for 79% of all prescriptions for this species. Furunculosis was more frequent during the summer and early autumn, and in the western parts of Norway. Fish weighing more than 1 kg seemed to be the most susceptible. However, furunculosis has almost disappeared in Norwegian aquaculture since 1993. Vibriosis gave cause for antibiotic treatments in almost all fish species, and was the most common diagnosis in rainbow trout, halibut, turbot, cod and European eel. In Atlantic salmon, fish of small and medium size (up to 1 kg) seemed to be more at risk from vibriosis, and outbreaks were more frequent during summer, and in the western counties. Cold-water vibriosis was the second most frequently treated disease in Atlantic salmon, creating severe problems mainly in larger fish, in the northern parts of the country, and during winter and spring. The seasonal distribution was similar for winter ulcer disease, the only disease which seemed to be of increasing importance in Atlantic salmon. Non-specific diagnoses, such as 'bacterial infection' and 'fry disease', were given in a much higher proportion of prescriptions for marine fish species than in prescriptions for salmonids.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12650244     DOI: 10.3354/dao053115

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  6 in total

Review 1.  Antibiotic Application and Emergence of Multiple Antibiotic Resistance (MAR) in Global Catfish Aquaculture.

Authors:  Li-Oon Chuah; M E Effarizah; Abatcha Mustapha Goni; Gulam Rusul
Journal:  Curr Environ Health Rep       Date:  2016-06

Review 2.  The Promise of Whole Genome Pathogen Sequencing for the Molecular Epidemiology of Emerging Aquaculture Pathogens.

Authors:  Sion C Bayliss; David W Verner-Jeffreys; Kerry L Bartie; David M Aanensen; Samuel K Sheppard; Alexandra Adams; Edward J Feil
Journal:  Front Microbiol       Date:  2017-02-03       Impact factor: 5.640

3.  Seafood from a changing Arctic.

Authors:  Max Troell; Arne Eide; John Isaksen; Øystein Hermansen; Anne-Sophie Crépin
Journal:  Ambio       Date:  2017-12       Impact factor: 5.129

Review 4.  Integrating Genomic and Morphological Approaches in Fish Pathology Research: The Case of Turbot (Scophthalmus maximus) Enteromyxosis.

Authors:  Paolo Ronza; Diego Robledo; Roberto Bermúdez; Ana Paula Losada; Belén G Pardo; Paulino Martínez; María Isabel Quiroga
Journal:  Front Genet       Date:  2019-01-31       Impact factor: 4.599

Review 5.  Bacteriophages in the Control of Aeromonas sp. in Aquaculture Systems: An Integrative View.

Authors:  Carla Pereira; João Duarte; Pedro Costa; Márcia Braz; Adelaide Almeida
Journal:  Antibiotics (Basel)       Date:  2022-01-27

6.  A novel application of bubble-eye strain of Carassius auratus for ex vivo fish immunological studies.

Authors:  Hiroto Nakajima; Atsushi Miyashita; Hiroshi Hamamoto; Kazuhisa Sekimizu
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.